{
 "url": "https://etfiq.com/funds/gnom/holdings/",
 "section": "funds",
 "title": "GNOM Holdings: All 50 Positions (May 31, 2026) | ETFIQ",
 "description": "All 50 GNOM holdings with weights, as of May 31, 2026. The top 3 are Guardant Health Inc 5.59%, ILMN 4.82% and NTRA 4.15%. Free CSV download.",
 "as_of": "May 31, 2026",
 "ticker": "GNOM",
 "fund": "Global X Genomics & Biotechnology ETF",
 "fund_page": "https://etfiq.com/funds/gnom",
 "positions": 50,
 "positions_listed_on_page": 50,
 "lead": "GNOM held 50 positions as of May 31, 2026. Guardant Health Inc is the largest at 5.59%; the top 10 are 42.5% of the fund.",
 "source": {
  "name": "Form N-PORT filed with the SEC",
  "url": "https://www.sec.gov/Archives/edgar/data/1432353/000204825126006502/primary_doc.xml",
  "document": "the fund’s SEC filing",
  "book_date": "2026-05-31",
  "file_date": null
 },
 "top_positions": [
  {
   "rank": 1,
   "holding": "Guardant Health Inc",
   "ticker": "GH",
   "weight_pct": 5.593,
   "page": "https://etfiq.com/holdings/gh/"
  },
  {
   "rank": 2,
   "holding": "Illumina Inc",
   "ticker": "ILMN",
   "weight_pct": 4.823,
   "page": "https://etfiq.com/holdings/ilmn/"
  },
  {
   "rank": 3,
   "holding": "Natera Inc",
   "ticker": "NTRA",
   "weight_pct": 4.152,
   "page": "https://etfiq.com/holdings/ntra/"
  },
  {
   "rank": 4,
   "holding": "BioMarin Pharmaceutical Inc",
   "ticker": "BMRN",
   "weight_pct": 4.086,
   "page": "https://etfiq.com/holdings/bmrn/"
  },
  {
   "rank": 5,
   "holding": "Arrowhead Pharmaceuticals Inc",
   "ticker": "ARWR",
   "weight_pct": 4.071,
   "page": "https://etfiq.com/holdings/arwr/"
  },
  {
   "rank": 6,
   "holding": "Legend Biotech Corp",
   "ticker": "LEGN",
   "weight_pct": 4.045,
   "page": null
  },
  {
   "rank": 7,
   "holding": "Praxis Precision Medicines Inc",
   "ticker": "PRAX",
   "weight_pct": 4.007,
   "page": "https://etfiq.com/holdings/prax/"
  },
  {
   "rank": 8,
   "holding": "Twist Bioscience Corp",
   "ticker": "TWST",
   "weight_pct": 3.966,
   "page": "https://etfiq.com/holdings/twst/"
  },
  {
   "rank": 9,
   "holding": "Vertex Pharmaceuticals Inc",
   "ticker": "VRTX",
   "weight_pct": 3.949,
   "page": "https://etfiq.com/holdings/vrtx/"
  },
  {
   "rank": 10,
   "holding": "CRISPR Therapeutics AG",
   "ticker": "CRSP",
   "weight_pct": 3.846,
   "page": "https://etfiq.com/holdings/crsp/"
  },
  {
   "rank": 11,
   "holding": "Veracyte Inc",
   "ticker": "VCYT",
   "weight_pct": 3.639,
   "page": "https://etfiq.com/holdings/vcyt/"
  },
  {
   "rank": 12,
   "holding": "Qiagen N.V.",
   "ticker": "QGEN",
   "weight_pct": 3.536,
   "page": "https://etfiq.com/holdings/qia/"
  },
  {
   "rank": 13,
   "holding": "BioNTech SE",
   "ticker": "BNTX",
   "weight_pct": 3.412,
   "page": null
  },
  {
   "rank": 14,
   "holding": "Bio-Techne Corp",
   "ticker": "TECH",
   "weight_pct": 3.407,
   "page": "https://etfiq.com/holdings/tech/"
  },
  {
   "rank": 15,
   "holding": "Moderna Inc",
   "ticker": "MRNA",
   "weight_pct": 3.278,
   "page": "https://etfiq.com/holdings/mrna/"
  },
  {
   "rank": 16,
   "holding": "10X Genomics Inc",
   "ticker": "TXG",
   "weight_pct": 3.23,
   "page": "https://etfiq.com/holdings/txg/"
  },
  {
   "rank": 17,
   "holding": "Beam Therapeutics Inc",
   "ticker": "BEAM",
   "weight_pct": 3.087,
   "page": "https://etfiq.com/holdings/beam/"
  },
  {
   "rank": 18,
   "holding": "Eli Lilly & Co",
   "ticker": "LLY",
   "weight_pct": 2.315,
   "page": "https://etfiq.com/holdings/lly/"
  },
  {
   "rank": 19,
   "holding": "Ultragenyx Pharmaceutical Inc",
   "ticker": "RARE",
   "weight_pct": 2.25,
   "page": "https://etfiq.com/holdings/rare/"
  },
  {
   "rank": 20,
   "holding": "Caris Life Sciences Inc",
   "ticker": "CAI",
   "weight_pct": 2.03,
   "page": null
  },
  {
   "rank": 21,
   "holding": "Genscript Biotech Corp",
   "ticker": null,
   "weight_pct": 1.999,
   "page": null
  },
  {
   "rank": 22,
   "holding": "BillionToOne Inc",
   "ticker": null,
   "weight_pct": 1.973,
   "page": null
  },
  {
   "rank": 23,
   "holding": "Gilead Sciences Inc",
   "ticker": "GILD",
   "weight_pct": 1.953,
   "page": "https://etfiq.com/holdings/gild/"
  },
  {
   "rank": 24,
   "holding": "Astrazeneca PLC",
   "ticker": null,
   "weight_pct": 1.831,
   "page": "https://etfiq.com/holdings/azn/"
  },
  {
   "rank": 25,
   "holding": "Sarepta Therapeutics Inc",
   "ticker": "SRPT",
   "weight_pct": 1.798,
   "page": "https://etfiq.com/holdings/srpt/"
  }
 ],
 "top_positions_shown": 25,
 "cash": [
  {
   "holding": "Cash and other net assets",
   "weight_pct": 0.103
  }
 ],
 "weights": "share of net assets, as the source states them",
 "csv": "https://etfiq.com/funds/gnom/holdings/gnom-holdings.csv",
 "json_book": "https://etfiq.com/data/books/gnom.json",
 "markdown": "https://etfiq.com/funds/gnom/holdings/index.md",
 "publisher": {
  "@id": "https://etfiq.com/#org",
  "name": "ETFIQ",
  "url": "https://etfiq.com"
 },
 "license": "https://etfiq.com/license/",
 "license_text": "Figures ETFIQ computes are free to use with attribution: ETFIQ (etfiq.com). Issuer data stays under its owner's terms.",
 "citation": "ETFIQ, Holdings of GNOM, data as of May 31, 2026. https://etfiq.com/funds/gnom/holdings/"
}